Covid-19 roundup: AstraZeneca cuts Q1 vaccine supply to EU by a third — report; Sanofi, Translate usher another mRNA shot into clinic
Tensions between AstraZeneca and the EU are far from settling, as the pharma reportedly plans to cut supply of its Oxford-partnered vaccine to the bloc by about a third in the first quarter.
According to documents reviewed by Reuters, AstraZeneca now plans to deliver about 30 million doses to the EU by the end of March, as opposed to the 90 million initially promised in its contract. Another 20 million doses are now set to come in April, Reuters reported.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
